GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NEO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for NeoGenomics stock after gaining 0.658%
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Gain 0.66% PDF

The NeoGenomics stock price gained 0.658% on the last trading day (Thursday, 18th Apr 2024), rising from $13.68 to $13.77. During the last trading day the stock fluctuated 3.45% from a day low at $13.62 to a day high of $14.09. The price has been going up and down for this period, and there has been a -6.9% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 95 thousand more shares were traded than the day before. In total, 656 thousand shares were bought and sold for approximately $9.04 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $13.66 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.59% during the next 3 months and, with a 90% probability hold a price between $12.90 and $15.30 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NEO Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 0.658%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The NeoGenomics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.02 and $15.04. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NeoGenomics stock

NeoGenomics finds support from accumulated volume at $13.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.470 between high and low, or 3.45%. For the last week, the stock has had daily average volatility of 3.96%.

NeoGenomics is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NEO) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect NeoGenomics to open at $13.83, and during the day (based on 14 day Average True Range), to move between $13.15 and $14.39, which gives a possible trading interval of +/-$0.616 (+/-4.48%) up or down from last closing price. If NeoGenomics takes out the full calculated possible swing range there will be an estimated 8.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.75 (0.15%) than the resistance at $14.36 (4.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NeoGenomics stock A Buy?

NeoGenomics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.025 Sell Candidate Unchanged

Predicted Opening Price for NeoGenomics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$13.83 ( 0.412%) $13.77

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NEO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.30 3.82 %
R2 14.12 2.52 %
R1 14.01 1.72 %
Current price: 13.77
Support S1 13.65 -0.89 %
S2 13.54 -1.70 %
S3 13.36 -3.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.48 19.68 %
R2 16.45 19.46 %
R1 14.36 4.28 %
Current price 13.77
Support S1 13.75 -0.145%
S2 13.68 -0.654%
S3 0 .

NEO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 15, 2020 Dec 17, 2020 Dec 30, 2020 $0.400 0.738%

FAQ

What is the symbol for NeoGenomics Stock and on which exchange is it traded?
The symbol for NeoGenomics is NEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeoGenomics Stock?
NeoGenomics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy NeoGenomics Stock?
NeoGenomics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeoGenomics Stock.

What's the current price of NeoGenomics Stock?
As of the end of day on the 2024-04-18, the price of an NeoGenomics (NEO) share was $13.77.

What is the 52-week high and low for NeoGenomics Stock?
The 52-week high for NeoGenomics Stock is $21.22 and the 52-week low is $11.05.

What is the market capitalization of NeoGenomics Stock?
As of the 2024-04-18, the market capitalization of NeoGenomics is 1.746B.

When is the next earnings date for NeoGenomics?
The upcoming earnings date for NeoGenomics is Apr 30, 2024.
Click to get the best stock tips daily for free!

About NeoGenomics

NeoGenomics NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fl... NEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT